Cargando…

Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer

In a previous report we suggested that the estimation of prothymosin α (PTA) levels in primary breast tumours might be used to identify breast cancer patients at high risk for distant metastasis (Dominguez F et al (1993) Eur J Cancer29A: 893–897). Here the role of tumour PTA levels as predictor was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magdalena, C, Dominguez, F, Loidi, L, Puente, J L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363325/ https://www.ncbi.nlm.nih.gov/pubmed/10682670 http://dx.doi.org/10.1054/bjoc.1999.0968

Ejemplares similares

Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma.
por: Wu, C. G., et al.
Publicado: (1997)

Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?
por: Samara, P., et al.
Publicado: (2016)

Overexpression of Prothymosin Alpha Predicts Poor Disease Outcome in Head and Neck Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2011)

MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells
por: Wu, Cheng-Der, et al.
Publicado: (2011)

Development of a specific IgY-based ELISA for prothymosin alpha, a bioactive polypeptide with diagnostic and therapeutic potential()
por: Karachaliou, Chrysoula-Evangelia, et al.
Publicado: (2019)

Subcellular dissemination of prothymosin alpha at normal physiology: immunohistochemical vis-a-vis western blotting perspective
por: Kijogi, Caroline Mwendwa, et al.
Publicado: (2016)

Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide
por: Birmpilis, Anastasios I., et al.
Publicado: (2019)

Prothymosin α overexpression contributes to the development of pulmonary emphysema
por: Su, Bing-Hua, et al.
Publicado: (2013)

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness
por: Wärnberg, F, et al.
Publicado: (2001)

Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells
por: Lin, Yi-Te, et al.
Publicado: (2015)

Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes
por: Ioannou, Kyriaki, et al.
Publicado: (2013)

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
por: Bijker, N, et al.
Publicado: (2001)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer
por: Oshikiri, T, et al.
Publicado: (2001)

Proteomic Analysis of Pichindé virus Infection Identifies Differential Expression of Prothymosin-α
por: Bowick, Gavin C., et al.
Publicado: (2010)

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours
por: Witte, J H de, et al.
Publicado: (2001)

Primary tumour characteristics and axillary lymph node status in breast cancer
por: Yiangou, C, et al.
Publicado: (1999)

Identification of prothymosin-α1, the necrosis–apoptosis switch molecule in cortical neuronal cultures
por: Ueda, Hiroshi, et al.
Publicado: (2007)

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions
por: de Wilt, J H W, et al.
Publicado: (2000)

Number of apoptotic cells as a prognostic marker in invasive breast cancer
por: Jong, J S de, et al.
Publicado: (2000)

The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy
por: Nicolini, A, et al.
Publicado: (1999)

Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer
por: Merrie, A E H, et al.
Publicado: (1999)

Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)
por: Zhu, Yanping, et al.
Publicado: (2019)

Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma
por: Woitge, H W, et al.
Publicado: (2001)

The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers
por: Hamilton, J A, et al.
Publicado: (2000)

Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response
por: Cameron, D A, et al.
Publicado: (2000)

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats
por: Wilt, J H W de, et al.
Publicado: (1999)

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients
por: Foekens, J A, et al.
Publicado: (1999)

E-cadherin as a prognostic indicator in primary breast cancer
por: Parker, C, et al.
Publicado: (2001)

The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease
por: Doweck, I, et al.
Publicado: (2000)

Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as prognostic marker
por: Chia, S-J, et al.
Publicado: (2000)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Adenovirus-Mediated Prothymosin α Gene Transfer Inhibits the Development of Atherosclerosis in Apoe-Deficient Mice
por: Chang, Meng-Ya, et al.
Publicado: (2014)

Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker
por: Birmpilis, Anastasios I., et al.
Publicado: (2022)

First Evidence of the Expression and Localization of Prothymosin α in Human Testis and Its Involvement in Testicular Cancers
por: Venditti, Massimo, et al.
Publicado: (2022)

Non-Vesicular Release of Alarmin Prothymosin α Complex Associated with Annexin-2 Flop-Out
por: Ueda, Hiroshi
Publicado: (2023)

Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice
por: Gladka, Monika M, et al.
Publicado: (2022)

Oestrogen receptor-α variant mRNA expression in primary human breast tumours and matched lymph node metastases
por: Leygue, E, et al.
Publicado: (1999)

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
por: Bottini, A, et al.
Publicado: (2001)

Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours
por: Speirs, V, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_n0b5d3784mssk3p8h6khtud5nr